1. Synthesis, biological evaluation, and computational studies of N -benzyl pyridinium-curcumin derivatives as potent AChE inhibitors with antioxidant activity.
- Author
-
Al-Rifai NM, Al-Khalileh NM, Zahra JA, El-Barghouthi MI, and Darras FH
- Subjects
- Humans, Donepezil, Cholinesterase Inhibitors pharmacology, Antioxidants pharmacology, Structure-Activity Relationship, Acetylcholinesterase metabolism, Pain, Molecular Docking Simulation, Curcumin, Alzheimer Disease
- Abstract
A library of N -benzylpyridinium-based compounds, 7a-j and 8a-j , was designed and synthesised as potential acetylcholinesterase) AChE (inhibitors. An in vitro assay for the synthesised compounds showed that most compounds had significant AChE inhibitory activities at the nanomolar and submicromolar levels. The benzyl ( 8a ) and fluoro ( 8b ) derivatives were the most active, with IC
50 values ≤56 nM. Compound 7f, which had a benzyl moiety, showed the highest potency among all the target compounds, with an IC50 value of 7.5 ± 0.19 nM against AChE, which was higher than that of the activities of tacrine (IC50 = 30 ± 0.2 nM) and donepezil (IC50 = 14 ± 0.12 nM). Compounds with vanillin moieties exhibited antioxidant activity. Among the tested compounds, four derivatives ( 7f , 7 g , 8f, and 8 g ) exhibited superior AChE inhibitory activity, with Ki values of 6-16 nM, which were potent in the same range as the approved drug, donepezil. These compounds showed moderate antioxidant activities, as indicated by the results of the ABTS assay.- Published
- 2023
- Full Text
- View/download PDF